162 related articles for article (PubMed ID: 35857429)
1. Development of
Lambidis E; Chen CC; Baikoghli M; Imlimthan S; Khng YC; Sarparanta M; Cheng RH; Airaksinen AJ
Mol Pharm; 2022 Aug; 19(8):2971-2979. PubMed ID: 35857429
[TBL] [Abstract][Full Text] [Related]
2. Biological evaluation of integrin α
Lambidis E; Chen CC; Lumen D; Sánchez AIF; Sarparanta M; Cheng RH; Airaksinen AJ
Eur J Pharm Sci; 2023 Jan; 180():106336. PubMed ID: 36403717
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and ex vivo biodistribution of two
Lambidis E; Lumén D; Koskipahta E; Imlimthan S; Lopez BB; Sánchez AIF; Sarparanta M; Cheng RH; Airaksinen AJ
Nucl Med Biol; 2022; 114-115():151-161. PubMed ID: 35680503
[TBL] [Abstract][Full Text] [Related]
4. Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods.
Chen CC; Stark M; Baikoghli M; Cheng RH
J Vis Exp; 2018 May; (135):. PubMed ID: 29806824
[TBL] [Abstract][Full Text] [Related]
5. Preparation and
Polyak A; Naszalyi Nagy L; Mihaly J; Görres S; Wittneben A; Leiter I; Bankstahl JP; Sajti L; Kellermayer M; Zrínyi M; Ross TL
J Pharm Biomed Anal; 2017 Apr; 137():146-150. PubMed ID: 28119212
[TBL] [Abstract][Full Text] [Related]
6. A comparative PET imaging study of
Ferguson S; Wuest M; Richter S; Bergman C; Dufour J; Krys D; Simone J; Jans HS; Riauka T; Wuest F
Nucl Med Biol; 2020; 90-91():74-83. PubMed ID: 33189947
[TBL] [Abstract][Full Text] [Related]
7. Convection-Enhanced Delivery of a Virus-Like Nanotherapeutic Agent with Dual-Modal Imaging for Besiegement and Eradication of Brain Tumors.
Pang HH; Chen PY; Wei KC; Huang CW; Shiue YL; Huang CY; Yang HW
Theranostics; 2019; 9(6):1752-1763. PubMed ID: 31037136
[TBL] [Abstract][Full Text] [Related]
8. Preparation and preclinical evaluation of (66)Ga-DOTA-E(c(RGDfK))2 as a potential theranostic radiopharmaceutical.
Lopez-Rodriguez V; Gaspar-Carcamo RE; Pedraza-Lopez M; Rojas-Calderon EL; Arteaga de Murphy C; Ferro-Flores G; Avila-Rodriguez MA
Nucl Med Biol; 2015 Feb; 42(2):109-14. PubMed ID: 25316595
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of (68)Ga- and (177)Lu-DOTA-PEG4-LLP2A for VLA-4-Targeted PET Imaging and Treatment of Metastatic Melanoma.
Beaino W; Nedrow JR; Anderson CJ
Mol Pharm; 2015 Jun; 12(6):1929-38. PubMed ID: 25919487
[TBL] [Abstract][Full Text] [Related]
10. Preclinical comparison of Al18F- and 68Ga-labeled gastrin-releasing peptide receptor antagonists for PET imaging of prostate cancer.
Chatalic KL; Franssen GM; van Weerden WM; McBride WJ; Laverman P; de Blois E; Hajjaj B; Brunel L; Goldenberg DM; Fehrentz JA; Martinez J; Boerman OC; de Jong M
J Nucl Med; 2014 Dec; 55(12):2050-6. PubMed ID: 25413139
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of (68) Ga-labeled Pteroyl-Lys conjugates for folate receptor-targeted tumor imaging.
Zhang X; Yu Q; He Y; Zhang C; Zhu H; Yang Z; Lu J
J Labelled Comp Radiopharm; 2016 Jul; 59(9):346-53. PubMed ID: 27320312
[TBL] [Abstract][Full Text] [Related]
12. CMKLR1-targeting peptide tracers for PET/MR imaging of breast cancer.
Erdmann S; Niederstadt L; Koziolek EJ; Gómez JDC; Prasad S; Wagener A; von Hacht JL; Reinicke S; Exner S; Bandholtz S; Beindorff N; Brenner W; Grötzinger C
Theranostics; 2019; 9(22):6719-6733. PubMed ID: 31588246
[No Abstract] [Full Text] [Related]
13. Comparative studies of three 68Ga-labeled [Des-Arg10]kallidin derivatives for imaging bradykinin B1 receptor expression with PET.
Lin KS; Amouroux G; Pan J; Zhang Z; Jenni S; Lau J; Liu Z; Hundal-Jabal N; Colpo N; Bénard F
J Nucl Med; 2015 Apr; 56(4):622-7. PubMed ID: 25745086
[TBL] [Abstract][Full Text] [Related]
14.
Bouziotis P; Stellas D; Thomas E; Truillet C; Tsoukalas C; Lux F; Tsotakos T; Xanthopoulos S; Paravatou-Petsotas M; Gaitanis A; Moulopoulos LA; Koutoulidis V; Anagnostopoulos CD; Tillement O
Nanomedicine (Lond); 2017 Jul; 12(13):1561-1574. PubMed ID: 28621567
[TBL] [Abstract][Full Text] [Related]
15. Development of a Ga-68 labeled PET tracer with short linker for prostate-specific membrane antigen (PSMA) targeting.
Moon SH; Hong MK; Kim YJ; Lee YS; Lee DS; Chung JK; Jeong JM
Bioorg Med Chem; 2018 May; 26(9):2501-2507. PubMed ID: 29655611
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive PET Imaging of a Ga-68-Radiolabeled RRL-Derived Peptide in Hepatocarcinoma Murine Models.
Huo Y; Kang L; Pang X; Shen H; Yan P; Zhang C; Liao X; Chen X; Wang R
Mol Imaging Biol; 2019 Apr; 21(2):286-296. PubMed ID: 29916116
[TBL] [Abstract][Full Text] [Related]
17. Radiolabeled R954 Derivatives for Imaging Bradykinin B1 Receptor Expression with Positron Emission Tomography.
Kuo HT; Pan J; Lau J; Zhang C; Zeisler J; Colpo N; Bénard F; Lin KS
Mol Pharm; 2017 Mar; 14(3):821-829. PubMed ID: 28094956
[TBL] [Abstract][Full Text] [Related]
18. Dual-Modality Imaging of Prostate Cancer with a Fluorescent and Radiogallium-Labeled Gastrin-Releasing Peptide Receptor Antagonist.
Zhang H; Desai P; Koike Y; Houghton J; Carlin S; Tandon N; Touijer K; Weber WA
J Nucl Med; 2017 Jan; 58(1):29-35. PubMed ID: 27516447
[TBL] [Abstract][Full Text] [Related]
19. Radiolabeled B9958 Derivatives for Imaging Bradykinin B1 Receptor Expression with Positron Emission Tomography: Effect of the Radiolabel-Chelator Complex on Biodistribution and Tumor Uptake.
Zhang Z; Amouroux G; Pan J; Jenni S; Zeisler J; Zhang C; Liu Z; Perrin DM; Bénard F; Lin KS
Mol Pharm; 2016 Aug; 13(8):2823-32. PubMed ID: 27348517
[TBL] [Abstract][Full Text] [Related]
20. In vivo preclinical evaluation of the new
Trencsényi G; Kis A; Szabó JP; Ráti Á; Csige K; Fenyvesi É; Szente L; Malanga M; Méhes G; Emri M; Kertész I; Vecsernyés M; Fenyvesi F; Hajdu I
Int J Pharm; 2020 Feb; 576():118954. PubMed ID: 31935470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
